Marco Cefali
Bellinzona, TI, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Transarterial Chemoembolization in Hepatocellular Carcinoma: Lessons from a 10-Year Real-World Retrospective Study.
Journal: Journal of hepatocellular carcinoma
Published: January 25, 2026
Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis.
Journal: Swiss medical weekly
Published: August 13, 2024
The active involvement of patients in oncology research.
Journal: Cancer treatment reviews
Published: June 28, 2024
Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes.
Journal: Cancers
Published: September 07, 2023
Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?
Journal: Cancers
Published: April 14, 2023
Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers.
Journal: Cancers
Published: July 15, 2022
Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy.
Journal: Journal of clinical medicine
Published: January 24, 2022
Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab.
Journal: Oncotarget
Published: March 23, 2021
Lymphocyte count and lymphocyte-to-white blood cells ratio as indicators of survival in specific cancer subtypes.
Journal: International immunopharmacology
Published: August 13, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026